Preliminary insights into the effects of spinal manipulation therapy of different force magnitudes on blood biomarkers of oxidative stress and pro-resolution of inflammation mediators

• Published in: Chiropractic & manual therapies Vol. 33; no. 1; pp. 8 - 14
• Main Authors: Duarte, Felipe C. K., Funabashi, Martha, Starmer, David, Partata, Wania A.
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 18.02.2025; BioMed Central; BMC
• Subjects: Adolescent; Adult; Analysis; Antioxidants; Asymptomatic; Back pain; Bilirubin; Biological markers; Biomarkers; Biomarkers - blood; Blood; COVID-19; Cytokines; Data collection; Enzyme-linked immunosorbent assay; Ethylenediaminetetraacetic acid; Female; Humans; Inflammation; Inflammation Mediators - blood; Lipids; Male; Manipulation; Manipulation, Spinal - methods; Medical research; Medicine, Experimental; Middle Aged; Neurophysiology; Neurosciences; Oxidative stress; Oxidative Stress - physiology; Resolvin D1; SARS-CoV-2; Spinal; Spinal manipulation; Young Adult; Spinal; Biomarkers; Oxidative stress; Resolvin D1; Manipulation; Blood
• ISSN: 2045-709X; 2045-709X
• DOI: 10.1186/s12998-025-00575-2

Evidence has been reported that spinal manipulation therapy (SMT) leads to spine segmental hypoalgesia through neurophysiological and peripheral mechanisms related to regulating inflammatory biomarker function. However, these studies also showed substantial inter-individual variability in the biomarker responses. Such variability may be due to the incomplete understanding of the fundamental effects of force-based manipulations (e.g., patient-specific force-time characteristics) on a person's physiology in health and disease. This study investigated the short-term effects of distinct SMT force-time characteristics on blood oxidative stress and pro-resolution of inflammation biomarkers. Nineteen healthy adults between 18 and 45 years old were recruited between February and March 2020 before the COVID-19 pandemic and clustered into three groups: control (preload only), target total peak force of 400 N, and 800 N. A validated force-sensing table technology (FSTT ) determined the SMT force-time characteristics. Blood samples were collected at pre-intervention, immediately after SMT, and 20 min post-intervention. Parameters of the oxidant system (total oxidant status, lipid peroxidation and lipid hydroperoxide), the antioxidant system (total antioxidant capacity and bilirubin), and lipid-derived resolvin D1 were evaluated in plasma and erythrocytes through enzyme-linked immunosorbent assay and colorimetric assays. The COVID-19 global pandemic impacted recruitment, and our pre-established target sample size could not be reached. As a result, there was a small sample size, which decreased the robustness of the statistical analysis. Despite the limitations, we observed that 400 N seemed to decrease systemic total oxidant status and lipid peroxidation biomarkers. However, 800 N appeared to transitorily increase these pro-oxidant parameters with a further transitory reduction in plasma total antioxidant capacity and resolvin D1 mediator. Despite the small sample size, which elevates the risk of type II error (false negatives), and the interruption of recruitment caused by the pandemic, our findings appeared to indicate that different single SMT force-time characteristics presented contrasting effects on the systemic redox signalling biomarkers and pro-resolution of inflammation mediators in healthy participants. The findings need to be confirmed by further research; however, they provide baseline information and guidance for future studies in a clinical population.